Minimum Investment
₹124,800
Price Range
₹196 to ₹208
Lot Size
600 shares
Issue Size
₹30 Cr
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.
Bookbuilding IPO
| Bid/Offer Opens On | 18-06-2026 |
| Bid/Offer Closes On | 22-06-2026 |
| Finalisation of Basis of Allotment | 23-06-2026 |
| Initiation of Refunds | 24-06-2026 |
| Credit of Shares to Demat | 24-06-2026 |
| IPO Listing Date | 25-06-2026 |
| Category | Offered Shares | Applied Shares | Times |
|---|---|---|---|
| QIB | 273,600 | 53,837,400 | 196.77x |
| NII | 207,000 | 123,709,800 | 597.63x |
| NII ( >10 lakh) | 138,000 | 92,566,800 | 670.77x |
| NII ( <10 lakh) | 69,000 | 31,143,000 | 451.35x |
| Retail | 481,200 | 0 | 0.00x |
| Total | 961,800 | 177,547,200 | 184.60x |
The lot size is 600 shares with a minimum investment of ₹124,800.
Bidding is scheduled from 18-06-2026 to 22-06-2026 (subject to exchange updates).
You can apply via the IPO Focuss - Ambica Finstock LLP mobile app during the bidding window using UPI or ASBA as available for this issue.
Shares are expected to list on 25-06-2026 (tentative; confirm from RHP / exchange notices).
Skyline Financial Services Pvt.Ltd.